Peter Vozzo | Investor Relations |
Neil McFarlane | Chief Executive Officer |
Vijay Shreedhar | Chief Commercial Officer |
Chris Prentiss | Chief Financial Officer |
Jason Butler | JMP |
Welcome to the Adamas Pharmaceuticals Second Quarter 2020 Financial Results Corporate Update Conference Call. [Operator Instructions] I would now like to turn the call over to Peter Vozzo, Investor Relations representative for Adamas Pharmaceuticals. Please go ahead.
Thank you, Gabriel, and good afternoon, everyone.
Before we begin, I would like to remind everyone that this call will contain forward-looking statements, which are subject to risks and uncertainties.